XML 68 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Series D Preferred Stock
Series E Preferred Stock
Series F Preferred Stock
Series G Preferred Stock
Preferred Stock
Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Series D Preferred Stock
Retained Earnings
Series E Preferred Stock
Retained Earnings
Series F Preferred Stock
Retained Earnings
Series G Preferred Stock
Treasury Stock, at Cost
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
[1]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
[1]
Beginning Balance, Preferred Shares (in shares) at Dec. 31, 2019           1,396,000                      
Beginning Balance, Common Shares (in shares) at Dec. 31, 2019             977,189,000                    
Beginning balance at Dec. 31, 2019 $ 17,038         $ 1,900 $ 1,257 $ 6,295 $ 12,469         $ (4,909) $ 26 $ (230) $ (230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (loss) 761               761                
Other comprehensive income (loss) 841                           841    
Deferred compensation 2             2                  
Cash dividends declared on common shares (542)               (542)                
Cash dividends declared on preferred stock   $ (20) $ (23) $ (18) $ (19)         $ (20) $ (23) $ (18) $ (19)        
Open market Common Share repurchases (in shares)             (6,067,000)                    
Open market Common Share repurchases (117)                         (117)      
Employee equity compensation program Common Share repurchases (in shares)             (1,815,000)                    
Employee equity compensation program Common Share repurchases (70)             (34)           (36)      
Common shares reissued (returned) for stock options and other employee benefit plans (in shares)             6,898,000                    
Common shares reissued (returned) for stock options and other employee benefit plans 122                         122      
Other (3)               (3)                
Ending Balance, Preferred Shares (in shares) at Sep. 30, 2020           1,396,000                      
Ending Balance, Common Shares (in shares) at Sep. 30, 2020             976,205,000                    
Ending balance at Sep. 30, 2020 17,722         $ 1,900 $ 1,257 6,263 12,375         (4,940) 867    
Beginning Balance, Preferred Shares (in shares) at Jun. 30, 2020           1,396,000                      
Beginning Balance, Common Shares (in shares) at Jun. 30, 2020             975,947,000                    
Beginning balance at Jun. 30, 2020 17,542         $ 1,900 $ 1,257 6,240 12,154         (4,945) 936    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (loss) 428               428                
Other comprehensive income (loss) (69)                           (69)    
Deferred compensation 2             2                  
Cash dividends declared on common shares (180)               (180)                
Cash dividends declared on preferred stock   (7) (8) (6) (6)         (7) (8) (6) (6)        
Open market Common Share repurchases (in shares)             0                    
Open market Common Share repurchases 0                         0      
Employee equity compensation program Common Share repurchases (in shares)             (1,000)                    
Employee equity compensation program Common Share repurchases 21             21           0      
Common shares reissued (returned) for stock options and other employee benefit plans (in shares)             259,000                    
Common shares reissued (returned) for stock options and other employee benefit plans 5             0           5      
Ending Balance, Preferred Shares (in shares) at Sep. 30, 2020           1,396,000                      
Ending Balance, Common Shares (in shares) at Sep. 30, 2020             976,205,000                    
Ending balance at Sep. 30, 2020 17,722         $ 1,900 $ 1,257 6,263 12,375         (4,940) 867    
Beginning Balance, Preferred Shares (in shares) at Dec. 31, 2020           1,396,000                      
Beginning Balance, Common Shares (in shares) at Dec. 31, 2020             975,773,000                    
Beginning balance at Dec. 31, 2020 17,981         $ 1,900 $ 1,257 6,281 12,751         (4,946) 738    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (loss) 1,996               1,996                
Other comprehensive income (loss) (783)                           (783)    
Deferred compensation 5             5                  
Cash dividends declared on common shares (534)               (534)                
Cash dividends declared on preferred stock   $ (20) $ (23) $ (18) $ (19)         (20) (23) (18) (19)        
Open market Common Share repurchases (in shares)             (27,346,000)                    
Open market Common Share repurchases (559)                         (559)      
Employee equity compensation program Common Share repurchases (in shares)             (1,604,000)                    
Employee equity compensation program Common Share repurchases (32)                         (32)      
Common shares reissued (returned) for stock options and other employee benefit plans (in shares)             7,274,000                    
Common shares reissued (returned) for stock options and other employee benefit plans 101             (28)           129      
Common share purchases under accelerated repurchase program (in shares)             (23,553,000)                    
Common share purchases under ASR program (585)             (117)           (468)      
Ending Balance, Preferred Shares (in shares) at Sep. 30, 2021   21,000 500,000 425,000 450,000 1,396,000                      
Ending Balance, Common Shares (in shares) at Sep. 30, 2021             930,544,000                    
Ending balance at Sep. 30, 2021 17,510         $ 1,900 $ 1,257 6,141 14,133         (5,876) (45)    
Beginning Balance, Preferred Shares (in shares) at Jun. 30, 2021           1,396,000                      
Beginning Balance, Common Shares (in shares) at Jun. 30, 2021             960,276,000                    
Beginning balance at Jun. 30, 2021 17,941         $ 1,900 $ 1,257 6,232 13,689         (5,287) 150    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (loss) 645               645                
Other comprehensive income (loss) (195)                           (195)    
Deferred compensation 5             5                  
Cash dividends declared on common shares (176)               (176)                
Cash dividends declared on preferred stock   $ (6) $ (7) $ (7) $ (5)         $ (6) $ (7) $ (7) $ (5)        
Open market Common Share repurchases (in shares)             (6,367,000)                    
Open market Common Share repurchases (125)                         (125)      
Employee equity compensation program Common Share repurchases (in shares)             (3,000)                    
Employee equity compensation program Common Share repurchases 0             0           0      
Common shares reissued (returned) for stock options and other employee benefit plans (in shares)             191,000                    
Common shares reissued (returned) for stock options and other employee benefit plans 25             21           4      
Common share purchases under accelerated repurchase program (in shares)             (23,553,000)                    
Common share purchases under ASR program (585)             (117)           (468)      
Ending Balance, Preferred Shares (in shares) at Sep. 30, 2021   21,000 500,000 425,000 450,000 1,396,000                      
Ending Balance, Common Shares (in shares) at Sep. 30, 2021             930,544,000                    
Ending balance at Sep. 30, 2021 $ 17,510         $ 1,900 $ 1,257 $ 6,141 $ 14,133         $ (5,876) $ (45)    
[1] Includes the impact of implementing ASU 2016-13, Financial Instruments - Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments. See Note 1 (“Summary of Significant Accounting Policies) in our 2020 Form 10-K for more information on our adoption of this guidance and the impact to our results of operations.